Cochrane for Clinicians
Putting Evidence into Practice
Influenza Vaccination for the Prevention of Cardiovascular Disease
FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.
FREE PREVIEW. Purchase online access to read the full version of this article.
Am Fam Physician. 2016 Mar 1;93(5):357-358.
Does influenza vaccination have any benefit for primary or secondary prevention of cardiovascular disease?
Influenza vaccination may reduce cardiovascular mortality in patients with established cardiovascular disease. The effect of vaccination is unclear among patients in the general population without known cardiovascular disease. (Strength of Recommendation: A, based on consistent, good-quality patient-oriented evidence.)
Globally, cardiovascular disease remains the number one cause of death.1 By 2030, it is estimated that the number of annual deaths from cardiovascular disease will increase to 23.3 million.1 Innovative strategies for primary and secondary prevention of cardiovascular disease are important. Observational studies have shown an association between receipt of the influenza vaccine and lower cardiovascular morbidity and mortality, especially among older and vulnerable populations.2,3 Another study found that influenza infection, but not influenza vacc
Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;(5):CD005050.
The practice recommendations in this activity are available at http://summaries.cochrane.org/CD005050.
REFERENCESshow all references
1. Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011....
2. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711–1720.
3. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373–1381.
4. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611–2618.
5. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 influenza season. MMWR Morb Mortal Weekly Rep. 2015;64(30):818–825.
6. UK Department of Health. Influenza: the Green Book. Chapter 19. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/456568/2904394_Green_Book_Chapter_19_v10_0.pdf. Accessed February 3, 2016.
These are summaries of reviews from the Cochrane Library.
This series is coordinated by Corey D. Fogleman, MD, Assistant Medical Editor.
A collection of Cochrane for Clinicians published in AFP is available at http://www.aafp.org/afp/cochrane.
Copyright © 2016 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions